• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

migraine - Articles and news items

amg 334

AMG 334 significantly reduces monthly migraine days in study

Industry news / 9 June 2016 / Victoria White, Digital Content Producer

Novartis has announced positive first results from a Phase II investigating the efficacy and safety of AMG 334 (erenumab) in chronic migraine prevention…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +